GlassScriptPhysician profile
Uy Q Ngo
NPI 1669552071
$20,946.93
in general payments reported to CMS, 2019-2025
24 companies · $4,005 in 2025
The $4,005 reported for 2025 was more than what 98% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,615 · 2022: $4,292 · 2023: $4,905 · 2024: $5,130 · 2025: $4,005.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Travel and Lodging: $700 · Honoraria: $188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,152.38 |
| Travel and Lodging | $699.58 |
| Honoraria | $187.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $10,214.29 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems, Heartmate Touch |
| Abiomed | $6,856.76 | 2021-2025 | Impella |
| Atricure, INC. | $1,282.56 | 2021-2025 | Atricure Cryoice Cryosphere Cryoablation System, Atriclip Laa Exclusion System |
| Cvrx, INC. | $639.35 | 2023-2025 | Barostim Neo System |
| Actelion Pharmaceuticals US, INC. | $232.39 | 2022-2025 | Opsumit, Uptravi |
| Zimmer Biomet Holdings, INC. | $218.09 | 2021 | |
| Baxter Healthcare | $214.14 | 2021-2024 | Floseal |
| Paragonix Technologies, INC. | $212.78 | 2022-2024 | Liverguard, Pancreaspak, Baroguard |
| One Lambda, INC. | $167.83 | 2021 | |
| Aroa Biosurgery Incorporated | $146.69 | 2022-2023 | |
| Astellas Pharma US INC | $131.98 | 2021-2024 | Cresemba |
| Medtronic, INC. | $127.57 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $116.07 | 2021-2023 | Livtencity |
| Impulse Dynamics (USA) INC. | $84.94 | 2024 | Optimizer |
| Pfizer INC. | $51.76 | 2022-2024 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries LP | $48.63 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.31 | 2023 | Jardiance |
| Biom'Up France Sas | $31.52 | 2021 | |
| Bridgebio Pharma, INC. | $30.64 | 2025 | Attruby |
| Novartis Pharmaceuticals Corporation | $22.52 | 2023 | |
| Ge Healthcare | $21.52 | 2025 | |
| Kls-Martin L.P. | $20.22 | 2021 | |
| Ethicon US, LLC | $18.53 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $12.84 | 2023 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Uy Ngo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.